Molecular Targets for Biological Therapies of Severe AsthmaCorrado Pelaia, Girolamo Pelaia, Caterina Tinello et al.|Frontiers in Immunology|2020Cited by 132
Tezepelumab: A Potential New Biological Therapy for Severe Refractory AsthmaCorrado Pelaia, Alessandro Vatrella, Giulia Pelaia et al.|International Journal of Molecular Sciences|2021Cited by 74
Real-life rapidity of benralizumab effects in patients with severe allergic eosinophilic asthma: Assessment of blood eosinophils, symptom control, lung function and oral corticosteroid intake after the first drug doseCorrado Pelaia, Girolamo Pelaia, Maria Teresa Busceti et al.|Pulmonary Pharmacology & Therapeutics|2019Cited by 62